Recent 8-K filings for TMO

• May 26, 2026, 7:31 AM ET other material materiality 0.15 negative item 5.07

  Thermo Fisher say-on-pay fails with 68% votes against at 2026 annual meeting

  All 11 director nominees elected; top vote-getter Debora L. Spar (314.4M for), lowest Dion J. Weisler (281.8M for).

• April 23, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  Thermo Fisher Q1 revenue $11.01B (+6% YoY); adjusted EPS $5.44 (+6%)

  Q1 revenue $11.01B, up 6% YoY; organic revenue growth 1%.

• March 24, 2026, 7:59 PM ET M&A materiality 0.50 neutral item 8.01item 9.01

  Thermo Fisher completes acquisition of Clario Holdings; no deal terms disclosed in filing

  Acquisition of Clario Holdings, Inc. completed on March 24, 2026.

• February 12, 2026, 6:59 PM ET debt materiality 0.75 neutral item 1.01item 8.01item 9.01 ◈ Material Agreements

  Thermo Fisher issues $3.8B in senior notes to partially fund Clario acquisition

  Issued four tranches: $1B 4.215% Notes due 2031, $750M 4.550% due 2033, $1.3B 4.902% due 2036, $750M 5.546% due 2046.

• January 29, 2026, 6:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01

  Thermo Fisher Q4 rev $12.21B (+7%), adj EPS $6.57 (+8%); FY rev $44.56B (+4%)

  Q4 GAAP diluted EPS $5.21 (+9%); adj EPS $6.57 (+8%); GAAP operating margin 18.5%.

• January 12, 2026, 6:59 PM ET leadership materiality 0.60 neutral item 5.02

  Thermo Fisher EVP/COO Lagarde and EVP Lowery to depart; Pettiti promoted to President and COO

  Michel Lagarde, EVP & COO, leaves March 31, 2026; Frederick Lowery, EVP, leaves Feb 28, 2026.

• December 1, 2025, 6:59 PM ET debt materiality 0.45 neutral item 1.01item 8.01item 9.01

  Thermo Fisher issues €2.1B in senior notes via finance subsidiary

  Issued €1.0B floating-rate notes due 2027 and €1.1B 3.628% notes due 2035.

• October 29, 2025, 7:59 PM ET M&A materiality 0.75 neutral item 8.01item 9.01

  Thermo Fisher to acquire Clario Holdings for $8.875B; deal expected to close mid-2026

  $8.875B cash at closing; additional $125M deferred and up to $400M contingent consideration.

• October 22, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Thermo Fisher Q3 revenue $11.12B (+5%); adjusted EPS $5.79 (+10%)

  Revenue $11.12B, +5% reported and +3% organic; GAAP EPS $4.27 vs $4.25 YoY.

• October 7, 2025, 7:59 PM ET debt materiality 0.55 neutral item 1.01item 8.01item 9.01

  Thermo Fisher issues $2.5B senior notes in four tranches due 2031–2037

  Issued $500M 4.200% notes due 2031, $750M 4.473% notes due 2032, $750M 4.794% notes due 2035, and $500M 4.894% notes due 2037.

• September 2, 2025, 7:59 PM ET M&A materiality 0.50 neutral item 8.01item 9.01

  Thermo Fisher completes acquisition of Solventum's purification and filtration business

  Transaction closed as of September 2, 2025.

• July 23, 2025, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  Thermo Fisher Q2: rev +3% to $10.85B, GAAP EPS $4.28 (+6%), adj EPS $5.36

  Q2 revenue $10.85B (+3% YoY; organic 2%); GAAP diluted EPS $4.28, up 6% from $4.04.

• July 23, 2025, 7:59 PM ET leadership materiality 0.60 neutral item 5.02

  Thermo Fisher CFO Stephen Williamson to retire March 2026; James Meyer named successor

  CFO Stephen Williamson will retire effective March 31, 2026.

• May 28, 2025, 7:59 PM ET other material materiality 0.15 negative item 5.07

  Thermo Fisher say-on-pay vote fails at 2025 annual meeting; all directors elected

  Non-binding advisory vote on executive compensation failed: 201.4M against vs 111.1M for (64.5% against).

• May 22, 2025, 7:59 PM ET other material materiality 0.70 positive item 5.02item 9.01

  Thermo Fisher grants CEO Casper $60M performance RSU award with TSR-based vesting through 2030

  Target award of 141,538 shares (~$60M) to CEO Marc Casper; cliff vesting May 21, 2030 contingent on TSR vs S&P 500.

• April 23, 2025, 7:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  Thermo Fisher Q1 GAAP EPS $3.98 (+15%), revenue $10.36B; agrees to acquire Solventum biz for $4.1B

  Q1 revenue $10.36B (+0.2% YoY); organic growth 1%; GAAP diluted EPS $3.98 (+15%).

• February 25, 2025, 6:59 PM ET M&A materiality 0.80 positive item 8.01

  Thermo Fisher to acquire Solventum's purification and filtration business for $4.1B

  Deal value approximately $4.1 billion in cash.

• February 19, 2025, 6:59 PM ET leadership materiality 0.25 neutral item 5.02 ◈ executive_change

  Thermo Fisher elects former CVS Health CEO Karen S. Lynch to its board

  Board size increased to 12; Lynch elected effective February 19, 2025, term until 2025 annual meeting.

• January 30, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Thermo Fisher Q4 revenue $11.40B (+5%), adj. EPS $6.10 (+8%)

  Q4 GAAP diluted EPS $4.78 (+14% YoY); adjusted EPS $6.10 (+8% YoY).

• October 23, 2024, 7:59 PM ET earnings materiality 0.65 neutral item 2.02item 9.01

  Thermo Fisher Q3 revenue flat at $10.60B; adjusted EPS $5.28; raises FY adjusted EPS guidance

  Revenue $10.60B, essentially flat versus $10.57B in Q3 2023; organic revenue also flat.

• July 24, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Thermo Fisher Q2 GAAP EPS $4.04 (+15%), Adj. EPS $5.37 (+4%), raises FY 2024 guidance

  Revenue $10.54B, down 1% YoY; organic revenue -1%, core organic revenue flat.

• July 10, 2024, 7:59 PM ET M&A materiality 0.50 neutral item 8.01item 9.01

  Thermo Fisher announces expiration and results of Olink tender offer

  TMO subsidiary Orion Acquisition AB concluded tender offer for all Olink common shares and ADRs.

• May 24, 2024, 7:59 PM ET other material materiality 0.15 neutral item 5.07

  Thermo Fisher annual meeting results: all directors elected, say-on-pay passes, simple majority proposal fails

  All 11 director nominees elected; highest votes for Debora L. Spar (318.2M for) and lowest for Marc N. Casper (291.6M for).

• April 24, 2024, 7:59 PM ET earnings materiality 0.82 positive item 2.02item 9.01 ◈ Earnings Releases

  Thermo Fisher Q1 rev $10.34B (-3%), GAAP EPS $3.46 (+4%), raises FY guidance

  GAAP diluted EPS $3.46 vs $3.32 YoY; adjusted EPS $5.11 vs $5.03 (+2%).

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.68 · Most common event earnings

9 positive 2 negative 13 neutral

source · TMO on sec.gov